Disclosures for "Chorea Revealing Antiphospholipid Syndrome: Implications for Stroke Secondary Prevention"
-
Dr. Orozco has nothing to disclose.
-
Dr. Sugar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie.